APOBEC3G: a double agent in defense.
APOBEC3G (A3G) is an effective cellular host defense factor under experimental conditions in which a functional form of the HIV-encoded protein Vif cannot be expressed. Wild-type Vif targets A3G for proteasomal degradation and when this happens, any host defense advantage A3G might provide is severely diminished or lost. Recent evidence cast doubt on the potency of A3G in host defense and suggested that it could, under some circumstances, promote the emergence of more virulent HIV strains. In this article, I suggest that it is time to recognize that A3G has the potential to act as a double agent. Future research should focus on understanding how cellular and viral regulatory mechanisms enable the antiviral function of A3G, and on the development of novel research reagents to explore these pathways.
Department of Biochemistry and Biophysics, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14642, USA. harold.smith@rochester.edu
Harold C
HC
Smith
D000071480:APOBEC-3G Deaminase; D003564:Cytidine Deaminase / Q000235:genetics / Q000378:metabolism*; D015658:HIV Infections / Q000235:genetics / Q000378:metabolism* / Q000821:virology; D015497:HIV-1 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D054884:Host-Pathogen Interactions; D006801:Humans; D008954:Models, Biological; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D011485:Protein Binding; D012313:RNA / Q000235:genetics / Q000378:metabolism; D013997:Time Factors; D014779:Virus Replication / Q000235:genetics; D054320:vif Gene Products, Human Immunodeficiency Virus / Q000235:genetics / Q000378:metabolism*
D054320:vif Gene Products, Human Immunodeficiency Virus; D012313:RNA; D046988:Proteasome Endopeptidase Complex; D000071480:APOBEC-3G Deaminase; C464924:APOBEC3G protein, human; D003564:Cytidine Deaminase
J Virol. 2009 Sep;83(17):8674-82
19535450
J Biol Chem. 2004 Feb 27;279(9):7792-8
14672928
J Virol. 2007 Sep;81(17):9577-83
17582006
Nature. 2003 Jul 3;424(6944):94-8
12808465
J Virol. 2006 Sep;80(17):8450-8
16912295
J Virol. 2007 Jul;81(13):7238-48
17428847
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3770-4
14999100
J Biol Chem. 2007 Nov 16;282(46):33632-33640
17848567
J Virol. 2007 Apr;81(8):3807-15
17267497
J Virol. 2010 Sep;84(18):9546-56
20610708
J Biol Chem. 2004 Aug 6;279(32):33177-84
15159405
Genes Dev. 2004 Dec 1;18(23):2867-72
15574593
J Biol Chem. 2006 Aug 4;281(31):22161-22172
16735504
J Virol. 2010 Oct;84(19):10402-5
20660203
Nat Struct Mol Biol. 2004 May;11(5):435-42
15098018
J Biol Chem. 2007 Nov 2;282(44):32065-74
17855362
RNA. 2008 Jun;14(6):1228-36
18456846
Nature. 2002 Aug 8;418(6898):646-50
12167863
J Biol Chem. 2010 May 28;285(22):16546-52
20363737
Mol Cell. 2003 Sep;12(3):591-601
14527406
Nat Biotechnol. 2008 Oct;26(10):1187-92
18806783
J Virol. 2009 Jan;83(2):1156-60
19004939
J Biol Chem. 2010 May 21;285(21):16195-205
20212048
J Biol Chem. 2004 Aug 20;279(34):35822-8
15210704
Trends Genet. 2003 Apr;19(4):207-16
12683974
Biochemistry. 2009 Nov 17;48(45):10685-7
19839647
J Virol. 2010 Nov;84(22):11981-93
20844042
J Biol Chem. 2003 Nov 7;278(45):44412-6
12970355
J Biol Chem. 2006 Dec 15;281(50):38122-6
17079235
J Virol. 2007 Jul;81(13):7099-110
17428871
Retrovirology. 2008 Mar 13;5:26
18339206
J Virol. 2006 Jun;80(12):5992-6002
16731938
PLoS Pathog. 2009 Mar;5(3):e1000330
19266078
J Cell Biochem. 2004 Jun 1;92(3):560-72
15156567
Retrovirology. 2007 Nov 24;4:81
18036235
J Virol. 2009 Sep;83(17):8646-54
19535442
J Virol. 2007 Aug;81(15):8201-10
17522216
J Biol Chem. 2004 Apr 9;279(15):14481-3
14966139
Virology. 2009 May 10;387(2):313-21
19304304
Nat Struct Mol Biol. 2006 May;13(5):392-9
16622407
J Virol. 2010 Jul;84(14):7396-404
20463080
J Virol. 2010 Jul;84(14):7135-9
20463065
J Biol Chem. 2004 Aug 13;279(33):34083-6
15215254
J Virol. 2006 Mar;80(6):3112-5
16501124
J Virol. 2006 Sep;80(18):9259-69
16940537
J Biol Chem. 2007 Feb 9;282(6):3539-46
17110377
J Virol. 2010 Oct;84(19):10209-19
20686027
J Biol Chem. 2005 Mar 25;280(12):10920-4
15647250
PLoS One. 2009 Aug 10;4(8):e6571
19668336
Genes Dev. 2004 Dec 1;18(23):2861-6
15574592
J Biol Chem. 2006 Sep 29;281(39):29105-19
16887808
PLoS Pathog. 2005 Sep;1(1):e6
16201018
PLoS Biol. 2004 Sep;2(9):E275
15269786
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7
15054139
J Virol. 2007 Mar;81(5):2165-78
17166910
Virology. 2008 Jan 5;370(1):113-21
17916373
PLoS Pathog. 2007 Feb;3(2):e15
17291161
Science. 2003 Nov 7;302(5647):1056-60
14564014
Virology. 2005 Mar 15;333(2):374-86
15721369
Cell. 2003 Jul 11;114(1):21-31
12859895
PLoS Pathog. 2008 Dec;4(12):e1000231
19057663
Curr Biol. 2005 Jan 26;15(2):166-70
15668174
Retrovirology. 2008 Jul 02;5:54
18597676
J Virol. 2003 May;77(10):5810-20
12719574
PLoS Pathog. 2009 Mar;5(3):e1000342
19300495
Nature. 2005 May 5;435(7038):108-14
15829920
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15588-93
17030807
J Virol. 2006 Jun;80(12):5984-91
16731937
Retrovirology. 2007 Jul 16;4:48
17631688
J Exp Med. 2006 Apr 17;203(4):865-70
16606671
J Virol. 1996 Aug;70(8):5297-305
8764040
Nature. 2003 Jul 3;424(6944):99-103
12808466
J Biol Chem. 2005 Mar 11;280(10):8765-75
15611076
Mol Cell Biol. 2005 Aug;25(16):7270-7
16055735
PLoS Pathog. 2006 May;2(5):e41
16699599
J Virol. 2007 Dec;81(23):13112-24
17881443
J Virol. 2007 Oct;81(20):11322-31
17670826
Nature. 2005 Jan 27;433(7024):430-3
15674295